Genenta Science S.p.A.
GNTA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001838716
No open-market purchases or sales by Genenta Science S.p.A. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.33M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −2 vs. previous quarter
- 9
- 13F valueReported value at the end of Q2 2026
- $1.33M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding GNTA, Q2 2026
No superinvestor reported holding GNTA at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Genenta Science S.p.A. insiders from Form 4, newest first.
No open-market purchases or sales by Genenta Science S.p.A. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Genenta Science S.p.A. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Eurizon Capital SGR S.p.A. | 360,000 | $662.4K | 0.00% | 00.0% | Unchanged |
| Allianz SE | 234,050 | $430.7K | 0.00% | 00.0% | Unchanged |
| SmartHarvest Portfolios, LLC | 43,856 | $80.7K | 0.03% | −90,591−67.4% | Reduced |
| Virtu Financial LLC | 36,913 | $68.0K | 0.00% | +36,913 | New |
| Simplicity Wealth,LLC | 18,590 | $34.2K | 0.00% | +6,379+52.2% | Added |
| Ground Swell Capital, LLC | 14,374 | $26.4K | 0.03% | +14,374 | New |
| GAMMA Investing LLC | 9,863 | $18.1K | 0.00% | −4,425−31.0% | Reduced |
| UBS Group AG | 3,027 | $5.57K | 0.00% | −80−2.6% | Reduced |
| Farther Finance Advisors, LLC | 3 | $6 | 0.00% | 00.0% | Unchanged |